Purdue Pharma L.P. Receives FDA Approval for Hysingla™ ER (hydrocodone(00) Donnie Prohaska 01 Aug 2025 Save Image Image gallery: Purdue Pharma: A Comprehensive Overview of Its Impact on the Opioid Crisis